Status:
TERMINATED
Validation Of A New S-ICD Algorithm To Reduce Oversensing Of Dynamic T-Waves In Patients With Brugada Syndrome
Lead Sponsor:
Angelo Auricchio
Conditions:
Brugada Syndrome 1S
Eligibility:
All Genders
18+ years
Brief Summary
The main objective of this study will be to assess the efficacy of S-ICD with SMART Pass to discriminate dynamic T-waves amplitudes and morphologies over time. Pilot, multi-centric, prospective, blin...
Detailed Description
The subcutaneous implantable cardioverter-defibrillator (S-ICD) should be considered as an alternative to transvenous defibrillators in patients with an ICD indication when pacing therapy for bradycar...
Eligibility Criteria
Inclusion
- Male and/or female subjects beyond the ages of ≥18 the time of informed consent;
- Subjects with suspected BrS;
Exclusion
- Presence of baseline Brugada type I ECG
- Presence of structural cardiac abnormalities
Key Trial Info
Start Date :
December 14 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2020
Estimated Enrollment :
126 Patients enrolled
Trial Details
Trial ID
NCT04504591
Start Date
December 14 2017
End Date
June 30 2020
Last Update
August 7 2020
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
UZ-VUB Brussels
Brussels, Belgium, B1090
2
Azienda Ospedaliera Brotzu
Cagliari, Italy, 09134
3
ATS Sardegna Ospedale San Francesco-ASSL 3 NUORO
Nuoro, Italy, 08100
4
Fondazione I.R.C.C.S. Policlinico San Matteo di Pavia
Pavia, Italy, 27100